Aaron S. Kesselheim aging Ameet Sarpatwari Beatrice Brown FDA Health Law Policy Patient Care Pharmaceuticals PORTAL Round-Up Professional Regulation
FDA
-
-
Addiction Health Law Policy Liability Mental Health Opioid Crisis Pain Pharmaceuticals Professional Regulation Public HealthTo Address the Overdose Epidemic, Tackle Pharma Industry Influence
Read more: To Address the Overdose Epidemic, Tackle Pharma Industry Influence -
Abortion Contraceptive Coverage COVID-19, Social Movements, and Health Digital Health FDA Featured Health Law Policy Judicial Opinions Patient Care Personhood Pharmaceuticals Pregnancy Privacy Public Health Supreme CourtCOVID-19 and the New Reproductive Justice Movement
Read more: COVID-19 and the New Reproductive Justice Movement -
Appeals Court Overturns FDA’s Partial Ban on Shock Devices: Analysis of Ruling
Read more: Appeals Court Overturns FDA’s Partial Ban on Shock Devices: Analysis of Ruling -
Contributors FDA Health Law Policy Human Subjects Research Immunization Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Scientific Evidence VaccinesWhy Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines?
Read more: Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines? -
Addiction Announcements Chloe Reichel FDA Featured Health Law Policy Informed Consent Insurance Intellectual Property Mason Marks Mental Health Neuroscience Off-Label Use Opioid Crisis Petrie-Flom Center Pharmaceuticals Public Health Race Research Funding Scientific EvidenceQ&A with Mason Marks on New Psychedelics Law and Regulation Initiative
Read more: Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative -
A Proposal for Localized Review to Safeguard Genetic Database Privacy
Read more: A Proposal for Localized Review to Safeguard Genetic Database Privacy -
COVID and the Law FDA Health Law Policy Human Subjects Research Patient Care Pharmaceuticals Public Health Scientific Evidence Vaccines“Stick to the Science”? FDA, Ethics, and Pandemics
Read more: “Stick to the Science”? FDA, Ethics, and Pandemics -
aging Beatrice Brown FDA Featured Geriatrics Health Care Finance Health Care Reform Medical Quality Medical Safety Medicare/Medicaid Patient Care Pharmaceuticals Public Health Resource AllocationFDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision?
Read more: FDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision? -
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs VaccinesWhat’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)?
Read more: What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)?